Will the BEAUTIFUL Study results change our views on heart rate control?

Abstract

The article describes the results of a randomized, double-blind, placebo-controlled, parallel-group BEAUTIFUL trial. The position of an If inhibitor ivabradine in the current algorithm of antianginal therapy is analyzed

Keywords

• стабильная стенокардия
• ингибитор if каналов
• ивабрадин